(Q44371330)

2 December 2017

Determination of protease inhibitors using liquid chromatography-tandem mass spectrometry (English)

1 reference

liquid chromatography-tandem mass spectrometry

2 December 2017

1 reference

Valerie A Frerichs

1

1 reference

2 December 2017

Robin DiFrancesco

series ordinal

2

1 reference

2 December 2017

Gene D Morse

series ordinal

3

1 reference

2 December 2017

1 April 2003

1 reference

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

2 December 2017

1 reference

2 December 2017

787

1 reference

2 December 2017

2

1 reference

2 December 2017

393-403

1 reference

describes a project that uses

2 December 2017

liquid chromatography-tandem mass spectrometry

1 reference

Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

Liquid chromatographic-tandem mass spectrometric determination of amprenavir (agenerase) in serum/plasma of human immunodeficiency virus type-1 infected patients receiving combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

Determination of amprenavir, a HIV-1 protease inhibitor, in human seminal plasma using high-performance liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detection

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

Quantitation of SR 27417 in human plasma using electrospray liquid chromatography-tandem mass spectrometry: A study of ion suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

Sample preparation for LC/MS/MS: analyzing biological and environmental samples

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2901002-4

7 January 2021

10.1016/S1570-0232(02)01002-4

Identifiers

DOI

1 reference

2 December 2017

1 reference